Search Within

Pamela Vaiskauskas

Formats
  1. Journal Article (3)
  2. Meeting Abstract (2)
Groups
  1. Center for Pancreatic Cancer Research (4)
  2. Department of Medicine (4)
  3. Department of Pathology and Laboratory Medicine (4)
  4. Gastrointestinal Oncology Service (4)
  5. Radiology, Department of (4)
  6. Solid Tumor Oncology Division (4)

More Groups

People
  1. Andrea Cercek Hanjis (4)
  2. Diane Reidy (4)
  3. Leonard Saltz (4)
  4. Jinru Shia (3)
  5. Nancy Kemeny (3)
  6. Neil Segal (3)

More People

Years
  1. 2021 (1)
  2. 2017 (1)
  3. 2016 (1)
  4. 2014 (1)
  5. 2012 (1)
Publications
  1. Journal of Clinical Oncology (2)
  2. Clinical Cancer Research (1)
  3. Clinical Colorectal Cancer (1)
  4. Clinical Journal of Oncology Nursing (1)
Publishers
  1. American Society of Clinical Oncology (2)
  2. American Association for Cancer Research (1)
  3. Elsevier Inc. (1)
  4. Oncology Nursing Society (ONS) (1)

Results (5)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase II single-arm study of durvalumab and tremelimumab with concurrent radiotherapy in patients with mismatch repair-proficient metastatic colorectal cancer
    Journal Article

    Segal, N. H.; Cercek, A.; Ku, G.; Wu, A. J.; Rimner, A.; Khalil, D. N.; Reidy-Lagunes, D.; Cuaron, J.; Yang, T. J.; Weiser, M. R.; more...
    Clinical Cancer Research (2021)

    Fulltext@MSK | Save
  • Checkpoint inhibitors: Common immune-related adverse events and their management
    Journal Article

    Gordon, R.; Kasler, M. K.; Stasi, K.; Shames, Y.; Errante, M.; Ciccolini, K.; Lucas, A. S.; Raasch, P.; Fischer-Cartlidge, E.
    Clinical Journal of Oncology Nursing (2017)

    Fulltext@MSK | Save
  • Non-randomized phase II study to assess the efficacy of pembrolizumab (Pem) plus radiotherapy (RT) or ablation in mismatch repair proficient (pMMR) metastatic colorectal cancer (mCRC) patients
    Meeting Abstract

    Segal, N. H.; Kemeny, N. E.; Cercek, A.; Reidy, D. L.; Raasch, P. J.; Warren, P.; Hrabovsky, A. E.; Campbell, N.; Shia, J.; Goodman, K. A.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Ganetespib, a novel Hsp90 inhibitor in patients with KRAS mutated and wild type, refractory metastatic colorectal cancer
    Journal Article

    Cercek, A.; Shia, J.; Gollub, M.; Chou, J. F.; Capanu, M.; Raasch, P.; Reidy-Lagunes, D.; Proia, D. A.; Vakiani, E.; Solit, D. B.; more...
    Clinical Colorectal Cancer (2014)

    Fulltext@MSK | Save
  • Phase II study of ganetespib, an hsp-90 inhibitor, in patients with refractory metastatic colorectal cancer
    Meeting Abstract

    Cercek, A.; Shia, J. R.; Gollub, M.; Raasch, P. J.; Hollywood, E.; Reidy, D. L.; Janjigian, Y. Y.; Stadler, Z. K.; Segal, N. H.; O'Reilly, E. M.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save